Study | Vitamin D reduces risk of ICU admission
From The Journal of Steroid Biochemistry and Molecular Biology
“Of 50 patients treated with calcifediol [bloodstream-form Vitamin D], one required admission to the ICU (2%), while of 26 untreated patients, 13 required admission (50%)… Of the patients treated with calcifediol, none died, and all were discharged, without complications. The 13 patients not treated with calcifediol, who were not admitted to the ICU, were discharged. Of the 13 patients admitted to the ICU, two died and the remaining 11 were discharged.”
Read the full study> Castillo, Marta Entrenas, et al. “Effect of Calcifediol Treatment and best Available Therapy versus best Available Therapy on Intensive Care Unit Admission and Mortality Among Patients Hospitalized for COVID-19: A Pilot Randomized Clinical study.” The Journal of Steroid Biochemistry and Molecular Biology (2020): 105751.